Skip to content

Effect of medicated Dry powder and ointment in Psoriasis.

A Clinical Evaluation of efficacy of vidangadi pradeh & Aragvadhadi udvartana in ek kushtha w.s.r to Psoriasis - CEVPAUEK

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/051214
Enrollment
30
Registered
2023-03-31
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

None listed

Sponsors

Dr Vijay kumar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients age between 20-50years irrespective of caste ,race gender. 2. The patient having classical signs and symptoms of EK-Kushtha(Psoriasis). 3. Patient willing to take part in Vidangadi Pradeha and Aragvadhadi Udvartana.

Exclusion criteria

Exclusion criteria: 1.Hypertension and other life threatening and complicated diseases (Ischemic Heart disease, Cancer, Stroke,HIV etc.) 2.Known case of Malignancy,IHD,CHF and any other vascular disease (Thrombo-angitis-Obliterans). 3.If any skin allergy. 4.Pregnant and Lactating women.

Design outcomes

Primary

MeasureTime frame
Marked improvement76%to100% Moderate improvement51%to75% Mild improvement26%to50% No improvement 0%to25% Timepoint: 4 weeks(30days)

Secondary

MeasureTime frame
Exacerbation in sign and symptomsTimepoint: 2 months

Countries

India

Contacts

Public ContactDR SHRIMANT G CHAVAN

Himalayiya Ayurvedic PG Medical College & Hospital, Dehradun

drsgc.hamc@gmail.com7204863633

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026